CRISPRMED24 Testimonial - Colette Rogers, Ph.D
By: WeDoCRISPR - Nov. 25, 2024
Colette Rogers PhD is a postdoctoral researcher at the University of Minnesota, working on the development of new gene-editing approaches to treat Fanconi anaemia. In this WeDoCRISPR video, she shares her thoughts on the inaugural CRISPR Medicine Conference which was held in Copenhagen in April 2024. Have a listen!
Tags
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Heterozygous familial hypercholesterolemia, (ChiCTR2400093099)
Sponsors:
Primary sponsor: The First Affiliated Hospital of Bengbu Medical College Primary sponsor's address: 287 Changhuai Road, Longzihu District, Bengbu, Anhui, China Secondary sponsor: Country: China Province: Anhui City: Bengbu Institution hospital: The First Affiliated Hospital of Bengbu Medical College Address: 287 Changhuai Road, Longzihu District
Sponsors:
Primary sponsor: The First Affiliated Hospital of Bengbu Medical College Primary sponsor's address: 287 Changhuai Road, Longzihu District, Bengbu, Anhui, China Secondary sponsor: Country: China Province: Anhui City: Bengbu Institution hospital: The First Affiliated Hospital of Bengbu Medical College Address: 287 Changhuai Road, Longzihu District
IND Enabling
Phase I
Phase II
Phase III